Analysed ELEDON PHARMACEUTICALS INC (ELDN:NASDAQ) News Sources
Eledon Announces Presentation of Updated Data from Investigator-Initiated Islet Transplant Trial of Tegoprubart in Patients with Type 1 Diabetes at American Diabetes Association (ADA) 2026 Scientific Sessions
04-06-2026
yahoo.com
Eledon Announces Updated Data from Investigator-Initiated Islet Transplant Trial of Tegoprubart in Patients with Type 1 Diabetes (T1D) at UChicago Medicine
08-06-2026
yahoo.com
Eledon Pharmaceuticals (ELDN) Announces Updated Results From Investigator-Initiated Trial Evaluating tegoprubart
10-06-2026
yahoo.com
Eledon Presents Long-Term Extension Phase 2 BESTOW Results at American Transplant Congress Showing Sustained Higher Kidney Function and Improved Patient-Reported Outcomes with Tegoprubart Compared with Tacrolimus
22-06-2026
yahoo.com
Natera and Eledon Announce Strategic Partnership for Prospera™ Monitoring in Planned Phase 3 Kidney Transplant Trial
25-06-2026
yahoo.com
NewcelX Announces Successful FDA Pre-IND Meeting with Clear Path Forward for NCEL-101 Toward Starting Clinical Trials for Type 1 Diabetes
01-07-2026
yahoo.com
NewcelX Appoints World-Renowned Diabetes Cure-Focused Pioneer, Dr. Camillo Ricordi, to Scientific Advisory Board
08-07-2026
yahoo.com
What is the current price of ELEDON PHARMACEUTICALS INC (ELDN:NASDAQ)?
The current price of ELEDON PHARMACEUTICALS INC (ELDN:NASDAQ) is $3.58.
ELEDON PHARMACEUTICALS INC (ELDN:NASDAQ) absolute price change since previous trading day?
The absolute price change of ELEDON PHARMACEUTICALS INC (ELDN:NASDAQ) since the previous trading day is $-0.16.
ELEDON PHARMACEUTICALS INC (ELDN:NASDAQ) percentage price change since previous trading day?
The percentage price change of ELEDON PHARMACEUTICALS INC (ELDN:NASDAQ) since the previous trading day is -4.2781%.
What is the most recent average sentiment score for ELEDON PHARMACEUTICALS INC (ELDN:NASDAQ)?
The most recent average sentiment score for ELEDON PHARMACEUTICALS INC (ELDN:NASDAQ) is 79 out of 100.
What is the most recent average sentiment for ELEDON PHARMACEUTICALS INC (ELDN:NASDAQ)?
The most recent sentiment for ELEDON PHARMACEUTICALS INC (ELDN:NASDAQ) is .
SEC-8K** Filing Available For ELEDON PHARMACEUTICALS INC (ELDN:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.